Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy

We established an automated method to expand high numbers of clinical-grade NK cells with properties similar to their manually produced counterparts. This automated process represents a highly efficient tool to standardize NK cell processing for therapeutic applications.